Literature DB >> 7238673

Indomethacin and cerebrovascular permeability to albumin in acute hypertension and cerebral embolism in the rat.

B B Johansson.   

Abstract

The experiments were performed to determine if indomethacin, a prostaglandin synthesis inhibitor, could reduce albumin extravasation and brain edema in some models of blood-brain barrier dysfunction. The blood pressure was increased by i.v. adrenaline or bicuculline in conscious rats with indwelling catheters in the aorta and jugular vein. 125I-labeled serum albumin and Evans blue-albumin were used as tracers of the blood-brain barrier function. Pretreatment with indomethacin significantly reduced albumin extravasation after the administration of adrenalin but not after bicuculline, i.e. when acute hypertension was combined with a metabolically mediated cerebral vasodilatation. It is argued that the protective effect of indomethacin in adrenaline-induced hypertension probably is related to the vasoconstrictory effect of the drug. Five microliters of air or Lipiodol were injected into the right internal carotid artery in rats anesthetized with pentobarbitone. The albumin content in the injected hemisphere was seven to nine times higher after fat than after air embolism. No significant reduction of tracer extravasation was obtained in rats treated with indomethacin. Rats subjected to fat embolism had a significant homolateral cerebral edema (i.e. increased water content) which was not reduced by pretreatment with indomethacin. By contrast, the water content was significantly increased also in the non-injected side in rats given indomethacin indicating a larger spread of edema fluid in these animals.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7238673     DOI: 10.1007/bf00237498

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  18 in total

1.  cAMP-mediated regulation of the permeability in the brain capillaries.

Authors:  F Joó; Z Rakonczay; M Wollemann
Journal:  Experientia       Date:  1975-05-15

2.  The pathophysiology of the blood-brain barrier dysfunction induced by severe hypercapnia and by epileptic brain activity.

Authors:  B Johansson; B Nilsson
Journal:  Acta Neuropathol       Date:  1977-05-16       Impact factor: 17.088

3.  Release of renal prostaglandin by catecholamines: relationship to renal endocrine function.

Authors:  P Needleman; J R Douglas; B Jakschik; P B Stoecklein; E M Johnson
Journal:  J Pharmacol Exp Ther       Date:  1974-02       Impact factor: 4.030

4.  Indomethacin causing pseudotumor cerebri in Bartter's syndrome.

Authors:  H Konomi; M Imai; K Nihei; S Kamoshita; H Tada
Journal:  N Engl J Med       Date:  1978-04-13       Impact factor: 91.245

5.  The effect of acute arterial hypertension on the blood-brain barrier to protein tracers.

Authors:  B Johansson; C L Li; Y Olsson; I Klatzo
Journal:  Acta Neuropathol       Date:  1970       Impact factor: 17.088

6.  Inhibition of prostaglandin synthesis and the response of baboon cerebral circulation to carbon dioxide.

Authors:  J D Pickard; E T Mackenzie
Journal:  Nat New Biol       Date:  1973-10-10

7.  Effect of an acute increase of the intravascular pressure on the blood-brain barrier: a comparison between conscious and anesthetized rats.

Authors:  B B Johansson
Journal:  Stroke       Date:  1978 Nov-Dec       Impact factor: 7.914

8.  Response of the cerebral circulation in baboons to changing perfusion pressure after indomethacin.

Authors:  J D Pickard; L A MacDonell; E T MacKenzie; A M Harper
Journal:  Circ Res       Date:  1977-02       Impact factor: 17.367

Review 9.  Prostaglandin and non-prostaglandin mediated breeakdown of the blood-aqueous barrier.

Authors:  K E Eakins
Journal:  Exp Eye Res       Date:  1977       Impact factor: 3.467

10.  Some factors influencing the damaging effect of acute arterial hypertension on cerebral vessels in rats.

Authors:  B B Johansson
Journal:  Clin Sci Mol Med Suppl       Date:  1976-12
View more
  5 in total

1.  Long-Term Treatment with Losartan Attenuates Seizure Activity and Neuronal Damage Without Affecting Behavioral Changes in a Model of Co-morbid Hypertension and Epilepsy.

Authors:  Jana D Tchekalarova; Natasha Ivanova; Dimitrina Atanasova; Daniela M Pechlivanova; Nikolai Lazarov; Lidia Kortenska; Rumiana Mitreva; Valentin Lozanov; Alexander Stoynev
Journal:  Cell Mol Neurobiol       Date:  2015-10-13       Impact factor: 5.046

Review 2.  Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage.

Authors:  Karol P Budohoski; Marek Czosnyka; Peter J Kirkpatrick; Peter Smielewski; Luzius A Steiner; John D Pickard
Journal:  Nat Rev Neurol       Date:  2013-02-19       Impact factor: 42.937

Review 3.  The Potential Therapeutic Capacity of Inhibiting the Brain Renin-Angiotensin System in the Treatment of Co-Morbid Conditions in Epilepsy.

Authors:  Natasha Ivanova; Jana Tchekalarova
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

4.  Effects of p-chlorophenylalanine on microvascular permeability changes in spinal cord trauma. An experimental study in the rat using 131I-sodium and lanthanum tracers.

Authors:  Y Olsson; H S Sharma; C A Pettersson
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

5.  Effects of prolonged versus acute indomethacin therapy in very low birth-weight infants with patent ductus arteriosus.

Authors:  P G Rhodes; M G Ferguson; N S Reddy; J A Joransen; J Gibson
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.